Fulgent Genetics Price to Book Ratio 2015-2024 | FLGT
Historical price to book ratio values for Fulgent Genetics (FLGT) over the last 10 years. The current price to book ratio for Fulgent Genetics as of May 09, 2025 is 0.53.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Fulgent Genetics Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-09 | 19.70 | 0.54 | |
| 2024-12-31 | 18.47 | $36.61 | 0.50 |
| 2024-09-30 | 21.73 | $37.16 | 0.58 |
| 2024-06-30 | 19.62 | $37.30 | 0.53 |
| 2024-03-31 | 21.70 | $37.69 | 0.58 |
| 2023-12-31 | 28.91 | $38.22 | 0.76 |
| 2023-09-30 | 26.74 | $42.01 | 0.64 |
| 2023-06-30 | 37.03 | $42.23 | 0.88 |
| 2023-03-31 | 31.22 | $42.74 | 0.73 |
| 2022-12-31 | 29.78 | $43.14 | 0.69 |
| 2022-09-30 | 38.12 | $43.17 | 0.88 |
| 2022-06-30 | 54.53 | $43.31 | 1.26 |
| 2022-03-31 | 62.41 | $43.29 | 1.44 |
| 2021-12-31 | 100.59 | $38.66 | 2.60 |
| 2021-09-30 | 89.95 | $35.01 | 2.57 |
| 2021-06-30 | 92.23 | $31.20 | 2.96 |
| 2021-03-31 | 96.62 | $27.65 | 3.49 |
| 2020-12-31 | 52.10 | $20.21 | 2.58 |
| 2020-09-30 | 40.04 | $8.02 | 4.99 |
| 2020-06-30 | 16.00 | $3.99 | 4.01 |
| 2020-03-31 | 10.76 | $3.75 | 2.87 |
| 2019-12-31 | 12.90 | $3.85 | 3.35 |
| 2019-09-30 | 10.39 | $2.92 | 3.56 |
| 2019-06-30 | 6.68 | $2.78 | 2.40 |
| 2019-03-31 | 5.95 | $2.73 | 2.18 |
| 2018-12-31 | 3.17 | $2.81 | 1.13 |
| 2018-09-30 | 3.93 | $2.91 | 1.35 |
| 2018-06-30 | 4.14 | $2.93 | 1.41 |
| 2018-03-31 | 4.00 | $2.97 | 1.35 |
| 2017-12-31 | 4.38 | $3.04 | 1.44 |
| 2017-09-30 | 4.79 | $3.11 | 1.54 |
| 2017-06-30 | 6.39 | $3.14 | 2.03 |
| 2017-03-31 | 10.92 | $3.13 | 3.49 |
| 2016-12-31 | 11.57 | $3.08 | 3.75 |
| 2016-09-30 | 9.22 | $1.34 | 6.87 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.600B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.567B | 53.27 |
| Hims & Hers Health (HIMS) | United States | $11.630B | 120.84 |
| Tempus AI (TEM) | United States | $10.569B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.461B | 69.70 |
| IRhythm Technologies (IRTC) | United States | $4.396B | 0.00 |
| Privia Health (PRVA) | United States | $3.050B | 208.50 |
| Enovis (ENOV) | United States | $1.888B | 10.52 |
| Clover Health Investments (CLOV) | United States | $1.793B | 0.00 |
| Schrodinger (SDGR) | United States | $1.746B | 0.00 |
| Phreesia (PHR) | United States | $1.506B | 0.00 |
| Azenta (AZTA) | United States | $1.223B | 56.96 |
| Omnicell (OMCL) | United States | $1.208B | 21.31 |
| 10x Genomics (TXG) | United States | $1.073B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.509B | 151.00 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.406B | 0.00 |
| TruBridge (TBRG) | United States | $0.371B | 827.00 |
| Claritev (CTEV) | United States | $0.351B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.290B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.195B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
| Pulmonx (LUNG) | United States | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.107B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.089B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.088B | 0.00 |
| CareCloud (CCLD) | United States | $0.081B | 3.07 |
| 111 (YI) | China | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |